M. Lowe

Protection of normal proliferating cells against chemotherapy by staurosporine-mediated, selective, and reversible G(1) arrest.

D. Lawrence, K. Keyomarsi, X. Chen, 2000, Journal of the National Cancer Institute.

Lovastatin mediated G1 arrest in normal and tumor breast cells is through inhibition of CDK2 activity and redistribution of p21 and p27, independent of p53

K. Keyomarsi, M. Lowe, T. Herliczek, 1998, Oncogene.

Taxol-induced apoptosis depends on MAP kinase pathways (ERK and p38) and is independent of p53

Y. Yarden, K. Keyomarsi, A. Gudkov, 2001, Oncogene.

UCN-01-mediated G1 arrest in normal but not tumor breast cells is pRb-dependent and p53-independent

K. Keyomarsi, M. Lowe, Xiaomei Chen, 1999, Oncogene.

Cyclin E and survival in patients with breast cancer.

Isabelle Bedrosian, Thaddeus W Herliczek, Michael Lowe, 2002, The New England journal of medicine.

Activation of the estrogen-signaling pathway by p21(WAF1/CIP1) in estrogen receptor-negative breast cancer cells.

K. Keyomarsi, X. Chen, M. Lowe, 2000, Journal of the National Cancer Institute.

Lovastatin-mediated G1 arrest is through inhibition of the proteasome, independent of hydroxymethyl glutaryl-CoA reductase.

K. Keyomarsi, S. Rao, X. Chen, 1999, Proceedings of the National Academy of Sciences of the United States of America.